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Neural stem cells (NSCs) expressing GFP were
embedded into fibrin matrices containing growth
factor cocktails and grafted to sites of severe spinal
cord injury. Grafted cells differentiated into multiple
cellular phenotypes, including neurons, which ex-
tended large numbers of axons over remarkable dis-
tances. Extending axons formed abundant synapses
with host cells. Axonal growth was partially depen-
dent on mammalian target of rapamycin (mTOR),
but not Nogo signaling. Grafted neurons supported
formation of electrophysiological relays across sites
of complete spinal transection, resulting in functional
recovery. Two human stem cell lines (566RSC and
HUES7) embedded in growth-factor-containing fibrin
exhibited similar growth, and 566RSC cells sup-
ported functional recovery. Thus, properties intrinsic
to early-stage neurons can overcome the inhibitory
milieu of the injured adult spinal cord to mount
remarkable axonal growth, resulting in formation of
new relay circuits that significantly improve function.
These therapeutic properties extend across stemcell
sources and species.INTRODUCTION
Research over the last several decades has revealed numerous
molecular mechanisms in the environment of the adult central
nervous system (CNS) that contribute to the failure of axonal
regeneration after injury, including myelin-associated proteins
that inhibit axonal growth (He and Koprivica, 2004; Buchli and
Schwab, 2005), the deposition of inhibitory extracellular matrix
molecules around injury sites (Fawcett, 2006; Fitch and Silver,
2008), and the lack of positive environmental stimuli such as1264 Cell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc.growth factors (Tuszynski and Lu, 2008). The observation that
at least some classes of adult CNS axons can grow over long
distances in peripheral nerve bridges supports the view that the
adult CNS environment is inhibitory (David and Aguayo, 1981;
Houle et al., 2006). However, some studies indicate that
neuron-intrinsic mechanisms also contribute to axonal growth
failure in the adult CNS (Filbin, 2006; Kadoya et al., 2009). Indeed,
the extent to which neuron-intrinsic mechanisms alone can over-
come the inhibitory growth environment of the adult CNS is
actively debated. To address this question, we grafted either
freshly dissociated neural stemcells/progenitors fromgreen fluo-
rescent protein (GFP)-expressing rat embryos (Bryda et al., 2006;
Baska et al., 2008; Mayer-Proschel et al., 1997) or cultured
human stem cells derived from two different sources (HUES7
cells and 566RSC cells from NeuralStem, Inc.) to the adult
lesioned spinal cord. Expression of the GFP reporter gene in all
cells provides an unprecedented opportunity to track the fate,
integration, process extension, and differentiation of grafted cell
types within the inhibitory milieu of the adult injured spinal cord.
We now report a remarkable capability of early-stage neurons
from different sources and species to survive, integrate, and
extend axons over very long distances and to form functional
relays in the lesioned adult CNS. These findings indicate that,
despite the inhibitory milieu of the adult CNS, neuron-intrinsic
mechanisms are sufficient to support remarkably extensive
axonal growth and synapse formation after spinal cord injury,
resulting in formation of new neuronal relays that restore elec-
trophysiological activity and behavior. Moreover, stem cells
across species exhibit these properties, supporting the intrinsic
capabilities of these cells and suggesting translational relevance.
RESULTS
Fischer 344 adult rats underwent T3 complete spinal cord tran-
section. Two weeks later, a clinically relevant time point, we
dissected embryonic day 14 (E14) spinal cords from Fischer
344 rats ubiquitously expressing the GFP reporter gene. Grafts
Figure 1. Survival, Filling, and Differentiation of Neural Stem Cell
Grafts in T3 Complete Transection Site
(A and B) Overview of GFP and GFAP fluorescent immunolabeling in a hori-
zontal section demonstrates excellent graft survival, integration, and filling of
T3 complete transection site 7 weeks postgrafting.
(C and D) GFP and NeuN labeling confirm extensive neuronal differentiation/
maturation of grafted rat neural stem cells.
(E and F) Higher magnification from (C) showing excellent integration and
transition from host (h) neurons to grafted (g) neurons (dashed lines) (E: GFP
and NeuN; F, NeuN alone).
(G and H) Higher magnification from center of graft showing high density of
NeuN-labeled neurons (inset) (G: GFP and NeuN; H, NeuN alone).
Scale bar, 320 mm (A–D) and 48 mm (E–H). Also see Figures S1 and S2.were trypsinized and implanted as suspensions (Giovanini et al.,
1997) but survived only at the host/lesion margins and failed to
fill the complete transection site. To enhance graft survival
and filling of the lesion, in new experiments, the E14 neural
stemcellswere embedded into fibrinmatrices containing a cock-
tail of growth factors (n = 26 rats; see Experimental Procedures).
Animals then underwent functional and electrophysiological
studies and were perfused 9 weeks after the initial injury.
Anatomical analysis revealed that grafted cells completely and
consistently filled the lesion cavity when assessed 7 weeks post-
grafting (Figures 1A and 1B). Grafted cells were not observed to
migrate into the host beyond the immediate region of the graft/
lesion site. Grafted cells primarily differentiated into neurons
(27.5 ± 2.7% of all GFP-labeled cells), oligodendroglia (26.6 ±C3.9%), and astrocytes (15.9 ± 1.6%) (Figures 1C–1H and Fig-
ure S1 available online). Numerous large GFP-labeled cells
colocalized with the mature neuronal markers NeuN (Figures
1C–1H), bIII tubulin (Tuj1), and MAP2 (Figures S2A and S2B). In
addition to expressing mature neuronal markers, many grafted
cells also expressed choline acetyltransferase (ChAT), character-
istic of spinal motor neurons, and the inhibitory neuronal marker
glutamic acid decarboxylase 67 (GAD67) (Figures S2C and S2D).
Graft-derived spinal cord neurons extended large numbers of
axons into the host spinal cord in both rostral and caudal direc-
tions over remarkably long distances (Figure 2). Emerging GFP-
labeled processes from grafts were axons, as demonstrated by
colabeling for the axonal marker neurofilament (Figure 2A). In the
cephalad (rostral) direction, graft-derived axons extended to C6
in all subjects examined (n = 6) and extended a distance of
25 mm from the T3 transection cavity into the C4 cervical
segment in five of six subjects (Figures 2E and 2F). Graft-derived
axons also extended caudally to the lower thoracic spinal cord
(T10) in all subjects (n = 6), continuing to the upper lumbar spinal
cord, which is a distance of more than nine spinal segments
(25 mm), in four of six subjects (Figures 2A–2D, 2G, and 2H).
All animals with caudal extension of axons to L1 also exhibited
rostral extension of axons to C4, indicating that long-distance,
bidirectional axonal growth occurred commonly. To estimate
the magnitude of axon outgrowth that can be achieved by
implantation of neural primordia into sites of spinal cord injury,
we stereologically (Rosenzweig et al., 2010) quantified 29,000
GFP-labeled axons emerging from the graft in the caudal direc-
tion (0.5 mm caudal to the T3 transection site). This number likely
represents an underestimation, as dense bundles of axons that
could not be individually resolved were counted as single axons.
The density of axons emerging from grafts was highly consistent
among all six subjects examined (Figure S3). In 12 additional
subjects, progressive axon emergence from the lesion/graft
site was serially examined at time points of 1, 2, 3, and 7 days
postgrafting (n = 3 rats per time point). Axons emerged from
the graft/lesion site by day 2 after grafting and extended at a rapid
rate of 1–2 mm/day (Figure S4). The visualization of axon growth
over time documents the extension of new axons and excludes
the possible artifact that grafted cells fused with host neurons.
Thus, axons extended in remarkably large numbers and over
long distances, including extension through adult white matter.
Indeed, time course studies indicated that initial axon outgrowth
preferentially occurred through white matter (Figure S4).
Graft-derived axons in host white matter were frequently
myelinated by host oligodendrocytes (i.e., cells myelinating
graft-derived axons were not labeled for GFP; Figures 3A
and 3B). In addition, grafted cells that differentiated into neurons
extended axons from the spinal cord lesion site into adjacent
host ventral roots in every subject examined, with 6.8 ± 1.2
graft-derived axons quantified per 40-mm-thick section of ventral
root (Figure S2E). 56.7 ± 5.3% of these ventral root axons ex-
pressed the appropriate phenotypic motor neuronal marker
ChAT (Figure S2F), likely derived from ChAT-expressing motor
neurons inside grafts (Figure S2C). GFP-labeled axons were
rarely detected in dorsal roots.
GFP-labeled, graft-derived axons in the host spinal cord
formed dense bouton-like terminals around host dendrites andell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc. 1265
Figure 3. Myelination, Synapse Formation, and Expression of
Neurotransmitters
(A and B) Graft-derived, GFP-labeled axons are myelinated in many cases
(red, myelin-associated glycoprotein, MAG), which is confirmed by electron
microscopy (T, transplanted, GFP-labeled axon).
(C and D) (C) GFP-expressing axon terminals are closely associated with
host MAP-2-expressing neurons and dendrites and (D) host Tuj1-expressing
neuronal somata.
(E) A z stack image triple-labeled for GFP, synaptophysin (Syn, inset), and
ChAT, indicating coassociation of graft-derived axons with a synaptic marker
in direct association with host motor neurons (arrowhead indicates one of
several examples).
(F) Electron microscopy confirms that DAB-labeled GFP-expressing axon
terminals form synapses (arrows) with host dendrites. Arrowhead indicates
a separate, host-host synapse.
(G and H) Expression of vGlut1/2 or GAD65 by GFP-labeled axons (arrows and
insets) in close association with host motor (ChAT-labeled) neurons.
Scale bar, 3mm (A); 200 nm (B); 8 mm (C–E); 200 nm (F); 7 mm (G); 6 mm (H).
Figure 2. Extensive Long-Distance Axonal Outgrowth from Neural
Stem Cell Grafts
(A) GFP and NeuN immunolabeling reveal that GFP-expressing neural stem
cell grafts robustly extend axons into the host spinal cord rostral and caudal to
the T3 complete transection site (caudal shown) over the 12 mm length of the
horizontal section. Extensive regions of the host spinal cord contain graft-
derived projections in white matter (WM) and gray matter (GM). Inset shows
that GFP-labeled projections arising from grafts express neurofilament (NF),
confirming their identity as axons.
(B) Light-level GFP immunolabeling also clearly reveals the density and
distribution of axons extending from the lesion site. Boxes are shown at higher
magnification in (C) and (D).
(C and D) (C) Dense numbers of GFP-labeled axons are present in host WM
and GM 1 mm caudal to the lesion, and (D) large numbers of axons remain at
the end of the block of tissue, 6 mm caudal to the lesion.
(E and F) (E) A high density of GFP-labeled axons is present in the lateral
portion of C8, three spinal segments above the lesion and (F) remain detect-
able at C4, seven spinal segments above the lesion. Asterisk indicates loca-
tions of higher magnification view.
(G and H) (G) GFP-labeled axons also extend in dense numbers caudally to T6
WM and GM (shown) and (H) caudally to L1. Overall, axons extend at least
25 mm in each direction.
Scale bar, 600 mm (A and B); 40 mm (C and D); and 10 mm (E–H). See also
Figures S3 and S4.cell bodies, identified by labeling for the neuronal somal and
dendritic markers MAP-2, the neuronal somal marker Tuj1 (bIII
tubulin), and the motor neuron marker ChAT (Figures 3C–3E).
Double immunofluorescent labeling for GFP and synaptophysin
suggested synapse formation between grafted and host neurons
in both rostral and caudal directions (Figure 3E) at all distances
from the lesion site, including sites sampled 25 mm from the1266 Cell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc.injury. Immunoelectron microscopy confirmed synapse forma-
tion between GFP-labeled graft-derived axons and host neurons
and dendrites (Figure 3F). Further, GFP-labeled terminal boutons
expressed either the excitatory transmitter marker vesicular
glutamate transporter 1/2 (vGlut1/2) or the inhibitory marker
glutamic acid decarboxylase 65 (GAD65) (Figures 3G and 3H).
Many instances of colocalization of these terminal region
markers with ChAT were also found (Figures 3G and 3H). Collec-
tively, these findings demonstrate exuberant projections of
Figure 4. Rapamycin Reduces Axon Growth; Host Axons Innervate
Grafts
(A) Treatment with the mTOR inhibitor rapamycin significantly reduced
outgrowth of graft-derived axons (*p < 0.05 and **p < 0.01; see also Figure S5).
Veh, vehicle; Rap, rapamycin treated. Data are represented as mean ±SEM.
(B and C) Host reticulospinal axons labeled with BDA regenerate into GFP-
expressing neural stem cell grafts in site of T3 complete transection (C, from
boxed area of (B); arrows indicate GFP-labeled grafted cells with neuronal
morphology).
(D and E) Host serotonergic axons immunolabeled for 5-HT regenerate into
GFP-expressing E14 neural stem cell grafts in lesion site.
(F) Bouton-like structures on host reticulospinal axons regenerating into graft
colocalize with synaptophysin in a z stack image (arrows).
(G) Host synaptophysin terminals (red) are closely apposed to GFP-labeled
grafted cells exhibiting neuronal morphology.
Scale bar, 64 mm (B); 12 mm (C); 70 mm (D); 10 mm (E); 2 mm (F and G).neural stem-cell-derived axons from sites of spinal cord injury
into the adult spinal cord together with synapse formation.
Neurons of the developing spinal cord express receptors to
myelin-associated inhibitors such as Nogo (Josephson et al.,
2002), a finding that we confirmed in the present study in grafted
tissue (Figure S5A). Thus, insensitivity to myelin-based inhibitors
is an unlikely mechanism to account for the robust growth of
axons observed in this study. Recently, the tumor suppressor
gene ‘‘phosphatase and tensin homolog’’ (PTEN) has been iden-
tified as amajor neuron-intrinsic regulator of axonal regenerationCin the adult CNS (Park et al., 2008). PTEN inhibits the activity of
‘‘mammalian target of rapamycin’’ (mTOR), and neuronal
knockout of PTEN has been reported to enhance central axonal
regeneration (Park et al., 2008; Liu et al., 2010; Sun et al., 2011).
To determine whether mTOR signaling is a mechanism contrib-
uting to the extensive growth of neural stem-cell-derived axons
through the lesioned adult CNS, we injected rapamycin, an
mTOR inhibitor, into rats beginning 2 days after placement of
grafts into the lesion site (6 mg/kg intraperitoneally, n = 6 rats;
seven controls underwent vehicle injections). When examined
2 weeks later, rats subjected to mTOR blockade exhibited
a significant, 50% reduction in graft-derived axonal outgrowth
from the lesion compared to vehicle-injected controls
(p < 0.05; Figures 4A and S5B–S5E). Labeling for phospho-S6
(p-S6), an indicator of mTOR activity (Park et al., 2008), demon-
strated abundant expression in graft-derived neurons and
substantial reduction following rapamycin treatment (Figures
S5H–S5J). Rapamycin injection did not alter neural stem cell
graft survival or differentiation (Figures S5F, S5G, and S5K).
These findings demonstrate mTOR signaling as a mechanism
contributing to the ability of early-stage neurons to extend axons
in the adult lesioned CNS.
Importantly, host axons also penetrated neural stem cell
grafts in spinal cord lesion sites, including biotin dextran amine
(BDA)-labeled reticulospinal axons and 5-hydroxytryptamine
(HT)-labeled serotonergic (raphespinal) axons (Figures 4B–4G).
Host inputs into grafts were both locally and supraspinally
derived. Although host supraspinal axons regenerated into
grafts, in no case did they regenerate beyond the graft into
host spinal cord parenchyma caudal to the lesion site. Like
graft-derived axons, host axons penetrating grafts colocalized
with the synaptic marker synaptophysin (Figure 4F), establishing
a mechanism for host-to-graft connectivity.
Functional and behavioral outcomes were measured in
subjects that underwent T3 complete spinal cord transections
and, 2 weeks later, neural stem cell implants in the lesion site
(Figure 5A). Hindlimb locomotion was severely impaired in both
lesion control and grafted subjects for the first 4 weeks postin-
jury; in week 5 (3 weeks postgrafting), recipients of neural stem
cell grafts exhibited significant improvement on the Basso,
Beattie, and Bresnahan (BBB) scale (Basso et al., 1996), reach-
ing a functional plateau by 8 weeks postlesion (p < 0.01). The
mean BBB score reached a level of seven, indicating movement
about each joint of the hindlimb, in contrast to minimal move-
ment, if any, in lesioned controls. To determine whether func-
tional improvement depended on regeneration of host axons
into the graft/lesion site, half of the subjects underwent retrans-
ection of the spinal cord just rostral to the T3 graft, resulting in
a complete abolition of behavioral recovery when measured
1 week later (Figures 5A and S6).
To confirm the dependence of functional recovery on host
axonal regeneration into the lesion site, electrophysiological
measurements were made in six subjects. A stimulating elec-
trode was placed in the dorsal C7 spinal cord (three spinal
segments above the lesion), and recordings were made at T6
(three spinal segments below the lesion). In intact animals,
stimulation at C7 evoked a short latency (3.42 ± 0.32 ms)
response (Figure 5B, i) that was entirely abolished by T3ell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc. 1267
Figure 5. Functional and Electrophysiological Improvement after T3
Complete Transection
(A) Hindlimb locomotion: BBB scores after T3 complete transection show
significant improvement in subjects that received neural stem cell grafts (NSC,
n = 6) compared to lesioned controls (n = 6). Retransection (arrow, Re-T) at
rostral interface of graft with host abolishes functional improvements when
assessed 1 week later (**p < 0.01 and ***p < 0.001). Data are represented as
mean ±SEM.
(B) Electrophysiological transmission across the T3 complete lesion site: (i) in
intact animals, stimulation at C7 evoked a short latency (3.0 ms), large
amplitude response at T6; (ii) transection of the cord at T3 completely
abolished this response; (iii) in four of six lesion/grafted animals, recovery of an
evoked response of prolonged latency (5.5 ms) was observed; (iv) and
retransection of the spinal cord at T3, just rostral to the graft (green arrow),
abolished the recovered evoked response.
(C) Kynurenic acid (50 mM), a blocker of excitatory synapses, was applied to
the graft to determine whether excitatory transmission across synapses in the
graft was required to detect responses at T6. Indeed, kynurenic acid appli-
cation substantially reduced the amplitude, but not the latency, of the evoked
response.
See also Figure S6.complete transection (Figure 5B, ii). In two-thirds of animals with
neural stem cell grafts in the lesion site, evoked responses were
restored (Figure 5B, iii). Response latencies in the grafted group1268 Cell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc.were prolonged (5.47 ± 0.24 ms, compared to 3.42 ± 0.32 ms in
intact subjects, p < 0.05), suggesting formation of polysynaptic
relays through the graft. Response amplitudes in the grafted
group (0.09 ± 0.03mV) were smaller than intact subjects
(0.27 ± 0.12mV) (p < 0.05; Figure 5B, iii). Notably, retransection
of the spinal cord just rostral to the T3 graft completely abolished
detectable activity upon C7 stimulation, even when using high
intensity stimuli (Figure 5B, iv). To determine whether responses
detected at T6 depended on the presence of synapses in the
graft, the N-methyl-D-aspartic acid (NMDA) receptor blocker
kynurenic acid (50 mM) was applied to the graft at T3, 7 weeks
postlesion. Kynurenic acid resulted in a significant, 50% reduc-
tion in the amplitude of the response recorded at T6 but did
not affect latency of the response, indicating that excitatory
synaptic transmission across the graft was required for detection
of caudal transmission (Figure 5C).
Thus, early-stage neurons grafted in a fibrin matrix containing
a growth factor cocktail extend large numbers of axons over long
distances in the lesioned spinal cord and form neuronal relays
that significantly improve electrophysiological and functional
outcomes. The magnitude of functional effect substantially
exceeds those previously reported in studies of fetal or stem
cell grafts to the injured spinal cord, possibly due to enhanced
graft survival generated by coimplantation with fibrin matrices
containing growth factors. These results suggest strong transla-
tional possibilities. Accordingly, we repeated these studies using
cultured human neural stem cells.
Six adult female athymic nude rats (T cell deficient) underwent
T3 complete transections. Oneweek later, a suspension of neural
stem cells derived from human fetal spinal cord (566RSC-UBQT-
GFP, see Experimental Procedures; gift of NeuralStem, Inc.) was
embedded into fibrin matrices containing a growth factor cock-
tail, as above. These cells are currently being used in a human
clinical trial in amytrophic lateral sclerosis (Boulis et al., 2011).
Function was assessed during the next 7 weeks in grafted
animals and was compared to six lesioned controls, and then
rats were sacrificed for anatomical studies. Grafts completely
and consistently filled lesion cavities (Figure 6A), and a majority
of grafted cells (57 ± 1.7%) expressed the mature neuronal
marker NeuN (Figure 6B). As in rat donor studies, remarkable
numbers of axons emerged from the grafts and extended for
very long distances, over a total of 17 spinal segments (Figures
6C–6E and 7). In the rostral direction, axons extended 25 mm
above the lesion site to the C4 level (Figures 7A–7C), and in
the caudal direction, axons reached the upper lumbar spinal
cord (Figures 7D–7F). GFP-labeled, graft-derived axons formed
bouton-like terminals in the host gray matter and expressed
human-specific synaptophysin (Figure 6F), suggesting synaptic
connectivity between grafted human and host rat neurons.
Tumor formation by implanted human neuronswas not observed
within the lesion site or remotely in the host spinal cord. As
observed in rat donor studies, grafts of human neural stem cells
induced significant locomotor recovery after T3 complete
transection (Figure 6G), with movement about all joints of the
lower extremities. Once again, retransecting the spinal cord
immediately rostral to the lesion site abolished hindlimb move-
ment, indicating that functional recovery was dependent on
inputs into the graft from the host.
Figure 7. Dense Axonal Outgrowth from Implants of Human 566RSC
Neural Stem Cells
(A) Very large numbers of GFP-labeled axons extend into host spinal cord
rostral to T3 transection site 7 weeks post-grafting. C8 segment is shown.
(B and C) GFP-labeled axons are present in C6 and C4 WM, five and seven
spinal segments above the lesion, respectively. Asterisks indicate location of
higher-magnification views.
(D–F) GFP-labeled axons also extend in high density caudal to T6 and T9 and
are present in both WM and GM (dashed lines indicate interface). (F) Axons
continue to extend caudally to L1. Overall, axons extend at least 25mm in each
direction in all subjects. Scale bar, 15 mm.
Figure 6. Human Neural Stem Cell Grafts in Fibrin Matrices after T3
Transection: Long-Distance Axonal Growth, Connectivity, and
Functional Improvement
(A) GFP-expressing 566RSC human NSCs survive and completely fill T3
complete transection site 7 weeks postgrafting (GFP, green and GFAP, red).
(B) GFP and NeuN labeling reveal that many grafted human neural stem cells
express mature neuronal markers. Field is from graft center.
(C–E) GFP-expressing human neurons robustly extend axons into the host
spinal cord caudal and rostral to the complete T3 transection site (caudal
shown). Axons extend through both WM and GM.
(F) GFP-labeled human axon terminals express human-specific synaptophysin
(hSyn) in host GM. Site shown is 7 mm caudal to lesion. Scale bar, 500 mm (A);
10 mm (B); 600 mm (C); 60 mm (D and E); and 3 mm (F).
(G) There is significant functional improvement after human NSC grafts to sites
of T3 complete transection (**p < 0.01). Retransection (arrow, Re-T) at rostral
interface of graft completely abolishes functional recovery assessed 1 week
later, indicating that host inputs are required to improve function.
Data are represented as mean ±SEM.To determine whether the ability to extend axons in vivo is
a property expressed by stem cells derived from different human
sources, we also tested the Harvard University Embryonic Stem
cell 7 (HUES7) line (Cowan et al., 2004). HUES7 cells were
neurally induced (Yuan et al., 2011) and embedded in the same
growth factor cocktail-containingmatrix and then grafted to sitesCof spinal cord injury (Figure S7); because this component of the
study was purely anatomical, we used a C5 lateral spinal cord
lesion (hemisection) in which animal care is less difficult. Once
again, remarkable numbers of axons extended from the
lesion over very long distances, reaching the brainstem in the
rostral direction and the lumbar spinal cord caudally (Figures
S7A–S7G). In gray matter, these human terminals abundantly
expressed the presynaptic marker synaptophysin (Figure S7H).
DISCUSSION
Findings of the present study indicate that neural stem cells can
specify sufficient information to permit extensive, long-distance
CNS axonal regeneration; additional experimental manipulation
of the inhibitory environment of the adult CNS is not required
to achieve this long-distance regeneration. Moreover, the axon
growth arising from neural stem cells can support functional
improvement in the most severe model of spinal cord injury,
complete spinal transection, when cografted in a supportive
fibrin matrix containing a growth factor cocktail. Axons extendell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc. 1269
in large numbers and over remarkably long distances to form
connections with host axons. Indeed, axons grew through white
matter, gray matter, and into ventral roots, and they grew in high
density and elongated at a rapid rate of 1–2 mm per day, even
through inhibitory white matter. Moreover, host supraspinal
axons regenerated into the neural stem cell grafts. This recip-
rocal growth resulted in a five-point improvement on the BBB
scale that reflects recovery of the ability to move all joints of
the hindlimbs. The mechanism of recovery, in contrast to
previous studies with neural stem cells, is functional relay forma-
tion, which is indicated by the abolition of recovery by spinal
retransection immediately rostral to the lesion. These findings
may accordingly represent themost comprehensive demonstra-
tion to date of the ability of new neural relays to support func-
tional recovery, even after the most severe spinal cord injury
(Steward et al., 2003).
Wictorin and colleagues reported in 1990 that early-stage
human fetal tissue grafted into partial striatal lesion sites could
extend axons for long distances in the mature CNS (Wictorin
et al., 1990). In 1997, Silver and colleagues also supported the
concept that neurons could extend axons through adult CNS
tissue over long distances by grafting adult dorsal root ganglion
neurons to white matter (Davies et al., 1997). However, these
neurons did not extend axons across lesion sites, and functional
effects were not studied (Davies et al., 1999). More recently,
Gaillard and colleagues reported long-distance extension of
GFP-labeled axons from embryonic grafts placed into cortical
lesion sites; this study was anatomical and lacked functional or
circuit analysis (Gaillard et al., 2007). Fischer’s group grafted
mixed neuronal and glial-restricted precursors to sites of partial
spinal cord injury but reported only modest axonal outgrowth
(Lepore and Fischer, 2005), and subsequent coadministration
of growth factors enabled further axonal growth over only short
distances of a few millimeters (Bonner et al., 2011). Previous
studies of embryonic stem cell implants to sites of spinal cord
injury used moderate and incomplete lesions and reported only
modest functional improvements (Cummings et al., 2005)
(1–2 points on the BBB scale), with relatively modest graft
survival in the lesion site. The classic embryonic spinal cord
grafting literature (Jakeman and Reier, 1991; Theele et al.,
1996; Bregman et al., 1997; Giovanini et al., 1997; Bamber
et al., 1999) used cells of a similar developmental stage to the
rodent donor cells in the present study but did not identify the
extent to which early-stage neurons were capable of extending
very large numbers of axons over extraordinarily long distances
in the lesioned adult nervous system; the improved survival,
growth, and outcomes in the present study are likely a result of
the use of fibrin matrix and a growth factor cocktail, together
with clear identification of cell fate and projection using the
GFP reporter. Indeed, distances traversed by graft-derived
axons in this study exceeded the length of the entire embryonic
rat nervous system (Miller et al., 1998). Findings were not attrib-
utable to graft cell fusion with the host, as axons progressively
elongated outward from the lesion over several days, which is
an observation inconsistent with cell fusion.
Grafts of human neural stem cells exhibited growth that was
equally extensive. Two different human cell sources, including
566RSC cells derived from human embryonic spinal cord (Johe1270 Cell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc.et al., 1996) and HUES7 cells derived from human embryonic
stem (ES) cells (Cowan et al., 2004; Yuan et al., 2011), exhibited
identical patterns of growth in the injured adult spinal cord after
neural induction. Thus, this growth potential is not cell specific
or species specific, suggesting translational potential. Indeed,
functional testing of 566RSC cells also revealed an ability to
support extensive functional improvement in a severe spinal
cord injury (SCI) lesion.
Conclusion
We report an extensive number, distance, and functional impact
of axonal outgrowth from neural stem cell grafts, embedded in
fibrinmatrices containing growth factors, to sites of severe spinal
cord injury. These findings indicate that properties intrinsic to the
early-stage neuron are sufficient to overcome barriers to growth
in the adult CNS. There are important potential clinical implica-
tions; treatments were delayed for a clinically practical time
frame of at least 1 week postinjury, resulted in significant func-
tional improvement, and were achieved by using a human neural
stem source already employed in clinical trials for amyotrophic
lateral sclerosis (ALS) (Boulis et al., 2011).
EXPERIMENTAL PROCEDURES
Animals
Adult female Fischer 344 rats (160–200 g, n = 55) and athymic nude rats (T cell
deficient) (180–200 g, n = 12) were subjects of this study. NIH guidelines for
laboratory animal care and safety were strictly followed. Animals had free
access to food and water throughout the study. All surgery was done under
deep anesthesia by using a combination (2 ml/kg) of ketamine (25 mg/ml),
xylazine (1.3 g/ml), and acepromazine (0.25 mg/ml).
Transplantation Surgeries
Adult female Fischer 344 rats and athymic nude rats underwent T3 complete
transection. A 2-mm-long block of spinal cord was cut and removed by using
a combination of iridectomy scissors and microaspiration, with visual verifica-
tion to ensure complete transection ventrally and laterally. For rat-donor
studies, grafting was performed 2 weeks after T3 transection. Embryonic
day 14 (E14) spinal cords from transgenic Fischer 344-Tg (EGFP) rats, ubiqui-
tously expressing GFP under the ubiquitin C promoter, provided donor tissue
for grafting (Rat Resource and Research Center, University of Missouri,
Columbia, MO). E14 spinal cord was dissected and dissociated according
to the method of Harris et al. (2007). Dissociated E14 cells were resuspended
at a concentration of 200,000 cells/ml in a fibrin matrix (25mg/ml fibrinogen and
25 U/ml thrombin, Sigma F6755 and T5772) containing growth factors to
support graft survival (Willerth et al., 2007; Grumbles et al., 2009; Kadoya
et al., 2009): BDNF (50 mg/ml, Peprotech, 452-02), neurotrophin-3 (NT-3;
50 mg/ml, Peprotech, 450-03), platelet-derived growth factor (PDGF-AA;
10 mg/ml, Sigma, P3076), insulin-like growth factor 1 (IGF-1; 10 mg/ml, Sigma,
I8779), epidermal growth factor (EGF; 10 mg/ml, Sigma, E1257), basic fibro-
blast growth factor (bFGF; 10 mg/ml, Sigma, F0291), acidic fibroblast growth
factor (aFGF; 10 mg/ml, Sigma, F5542), glial-cell-line-derived neurotrophic
factor (GDNF; 10 mg/ml, Sigma, G1401), hepatocyte growth factor (HGF;
10 mg/ml, Sigma, H9661), and calpain inhibitor (MDL28170, 50 mM, Sigma,
M6690). The graft mixture was microinjected into the lesion cavity as a 10 ml
cell suspension, and subjects survived another 7 weeks (n = 26). Animals
underwent functional testing, electrophysiological assessment, and anatom-
ical analysis and were compared to six lesion-only controls. To identify molec-
ular mechanisms underlying axonal outgrowth from donor cells, 13 additional
subjects underwent lesions and rat neural stem cell grafts and then received
either rapamycin (LC Laboratories, 6 mg/kg of 20 mg/ml solution; n = 6
animals) or vehicle (n = 7) intraperitoneally every other day starting 2 days post-
grafting, as previously described (Park et al., 2008). Animals survived an
additional 2 weeks. An additional 12 subjects underwent lesion and grafts and
were perfused 1, 2, 3, or 7 days after transplantation (n = 3 per time point) to
examine the time course of axonal outgrowth from the lesion site. Two weeks
before perfusion, reticulospinal tract axons were anterogradely labeled by
injection of 0.5 ml of 10% biotinylated dextran amine (BDA; MW10,000, Molec-
ular Probes) into each of four sites spanning both the right and left gigantocel-
lular reticular nucleus (bregma, 11–12.5mm; lateral, 8 mm; depth, 8.2–7.3 mm)
(Jin et al., 2002).
For human neural stem cell donor studies, cultured human fetal spinal cord
neural stem cells (NSCs) (NSI-566RSC) were provided by NeuralStem, Inc.
Methods for procuring cells have been published previously (Johe et al.,
1996; Boulis et al., 2011). Briefly, the cervical and upper thoracic region of
an 8 week human fetal spinal cord was dissociated and suspended by tritura-
tion in serum-free, modified N2 medium containing 100 mg/l human plasma
apo-transferrin, 25 mg/l recombinant human insulin, 1.56 g/l glucose, 20 nM
progesterone, 100 mM putrescine, and 30 nM sodium selenite in DMEM/F12.
10 ng/ml FGF2 was added as a mitogen, and cells were serially expanded as
monolayer cultures in T175 flasks or 150 mm plates coated with 100 mg/ml
poly-D-lysine (Johe et al., 1996). FGF2 was added every 2 days, and cells
were first passaged on day 16. Cells were harvested at each subsequent
passage upon reaching 75% confluence and were stored in liquid nitrogen.
They were not retained after passage 20. For shipping, cells were thawed
1 day prior to grafting, washed, and shipped overnight to UC San Diego at
2C –8C. Viability exceeded 80% the next day. Cells expressed GFP under
the ubiquitin C promoter, enabling in vivo tracking of cell survival, differentia-
tion, and process outgrowth. Cells were implanted into spinal cord lesion sites
1 week after T3 complete transection (n = 6 animals) and were compared to
lesioned, ungrafted controls (n = 6). Animals survived for 7 weeks and under-
went functional testing, as described above.
We also grafted a second human stem cell source. Proliferating HUES7
colonies were cultured on mouse fibroblasts and induced to form embryoid
bodies. During the nestin-positive stage, the rosettes were removed, single-
cell suspensions were prepared, and the CD184+/CD271/CD44/CD24+
population of hES-NSCs were fluorescence-activated cell (FAC)-sorted and
expanded in the presence of FGF-2 (Yuan et al., 2011). Cells were embedded
in fibrin matrices containing growth factors as described above and were
grafted into sites of C5 hemisection in adult female athymic (nude) rats
(n = 6). Comparison was made to lesioned, ungrafted controls (n = 6). Animals
survived for 3months and were sacrificed for anatomical studies, as described
above. This was a purely anatomical study; functional outcomes were not
examined.
Histology and Immunohistochemistry
Animals were perfused with 4% paraformaldehyde in 0.1 M phosphate buffer
(pH 7.2). Spinal cords were dissected, postfixed overnight at 4C, and then
transferred to 30% sucrose for 72 hr. 1.5-cm-long horizontal sections of spinal
cords containing the lesion/graft site were sectioned on a cryostat set at 30 mm
thickness. Coronal sections from the spinal cord, rostral and caudal to the T3
lesion/transplant site, were examined. Immunohistochemistry was performed
to assess survival, maturation, integration, and outgrowth of grafted neurons
as previously described (Lu et al., 2003). Free-floating sections were incubated
with primary antibodies against jellyfish GFP (rabbit, Invitrogen at 1:1,500 or
goat from Chemicon at 1:1,500 to label GFP-expressing neural stem cells);
GFAP (mouse from Chemicon at 1:1500 or rabbit from Dako at 1:1500 to label
astrocytes); NeuN (mouse from Chemicon at 1:200 to label mature neurons);
ChAT (goat from Chemicon at 1:200 to label spinal cord motor neurons and
motor axons); MAP-2 (mouse from Chemicon at 1:10,000 to label mature
neurons); ßIII tubulin (mouse from Chemicon at 1:500 to label immature and
mature neurons); neurofilament (NF; mouse from Chemicon at 1:1,500 to label
axons); serotonin (5-HT; polyclonal antibody from Immunostar at 1:20,000 to
label raphespinal axons); myelin-associated glycoprotein (MAG; mouse from
Chemicon at 1:200 to label myelin); glutamic acid decarboxylase 65 or 67
(GAD65, goat from RD System or GAD67, mouse from Millipore at 1:1,000
to label gabaergic neurons/terminals); vesicular glutamate transporters 1/2
(vGlut1/2, mouse from Chemicon at 1:1,000 to label glutamatergic terminals);
synaptophysin (mouse from Chemicon at 1:1,000 to label presynaptic termi-
nals); adenomatous polyposis coli (APC,monoclonal antibody fromOncogeneCat 1:400 to label oligodendrocytes); and phospho-S6 kinase (p-S6, rabbit from
Cell Signaling Technology at 1:200 to label ribosomal protein S6 phosphory-
lated at serine 235 and 236). Sections were incubated overnight at 4C and
then incubated in Alexa 488, 594, or 647 conjugated goat or donkey secondary
antibodies (1:250, Invitrogen) for 2.5 hr at room temperature. For nuclear stain-
ing, DAPI (200 ng/ml) was added to the final wash. BDA-labeled reticulospinal
tract axons were detected by double fluorescent labeling with GFP. After
blocking with 5% donkey serum, every sixth section was incubated with
primary antibody directed against GFP (rabbit) and Alexa 594-conjugated
streptavidin (to bind to BDA-labeled reticulospinal tract axons) overnight at
4C. After washes, sections were incubatedwith Alexa 488 conjugated donkey
anti-rabbit secondary antibodies for 2.5 hr at room temperature.
For examination and quantification of GFP-labeled axons, light-level GFP
immunolabeling was performed in every sixth section incubated overnight at
4C with GFP primary antibody (rabbit at 1:3,000) and then with horseradish
peroxidase (HRP) conjugated secondary antibodies (1:50, Vector Laboratory,
Burlingame, CA) for 1 hr at room temperature. Diaminobenzidine (0.05%) with
nickel chloride (0.04%) were used as chromagens, with reactions sustained for
10 min at room temperature.
Quantification of Neural Cell Density and Axon Number
Cellular differentiation was determined by counting individual cells labeled for
NeuN, GFAP, or APC within a fixed box size of 1,600 3 1,200 pixels at 4003
magnification within the graft, divided by the total number of cells per sample
box labeled with DAPI. Two randomly selected fields corresponding to the
graft epicenter were counted in each subject for each label, and all analyses
were conducted in a blinded manner. An average of 170, 150, and 92 NeuN-,
APC-, and GFAP-labeled cells were counted in each of six grafted animals,
respectively, and divided by the mean number of DAPI-labeled nuclei in the
sampled field (a mean of 586 DAPI-labeled nuclei/field). The number of
GFP-labeled axons emerging from a typical graft placed at the T3 transection
site was quantified by using StereoInvestigator (MicroBrightField, http://www.
mbfbioscience.com) as previously described (Rosenzweig et al., 2010).
Briefly, in every sixth sagittal section, a dorsoventral line was drawn
500 mm caudal to the graft/host interface under 403magnification. The tissue
was then examined under 6003 magnification, and GFP-labeled axons that
intersected this line were marked and counted. The sampling fraction was
8.3%. In addition, GFP axon number was quantified in every sixth section
both rostral and caudal to the graft to study molecular mechanisms of axonal
growth after rapamycin treatment. Lesion margins were determined by using
GFAP and GFP double fluorescent immunolabeling, and axons crossing
a vertical line in horizontal sections 1, 3, and 5 mm rostral and caudal to
the lesion/graft border were counted at 2003 magnification. Total axon
number/subject was estimated by multiplying by the sampling fraction.
Observers were blinded to group identity in all surgical and quantitative
procedures.
Semiquantitative RT-PCR
For RT-PCR of NgR1, 500 ng total RNA from E14, P1, or adult spinal cord was
used as the template in a 20 ml reaction with random hexamer priming using the
Superscript III kit (Invitrogen). 1 ml RT product was used in standard PCR with
different cycle numbers. PCR primers: 1)ﾊGAPDH:ﾊTGGAGTCTACTGG
CGTCTT,ﾊTGTCATATTTCTCGTGGTTCA and 2) NgR1: AAGAGGGCGTC
CTCCGG, CGGCATGACTGGAAGCT.
Electron Microscopy
Electron microscopic analysis of synapse formation and myelination was
performed according to the methods of Knott et al. (2009). Briefly, two rats
with T3 complete transections that received rat neural stem cell grafts were
perfused with 4% paraformaldehyde plus 0.25% glutaraldehyde (survival
time 3 months), and spinal cord parenchyma 2 mm caudal to the lesion/graft
site was sectioned in the coronal plane and then immunolabeled for GFP
with Diaminobenzidine (DAB) and nickel chloride. Sections were then post-
fixed with 1% osmium tetroxide, dehydrated, embedded in Durcupan resin,
and sectioned at 60 nm thickness. Individual GFP-labeled axons or axonal
terminals were located and assessed by using an FEI 200KV Sphera micro-
scope at the UCSD CryoElectron Microscopy Facility.ell 150, 1264–1273, September 14, 2012 ª2012 Elsevier Inc. 1271
Electrophysiology
Descending transmission of electrical activity through grafts was assessed by
using previously described techniques (Bradbury et al., 2002). In brief, a bipolar
stimulating electrode, consisting of a pair of 85 mm tungsten microelectrodes
(0.5 MOhm, WPI, Inc.) spaced 1 mm apart, was lowered 300–500 mm into the
cord at the C7 spinal segment. Brief (0.1 ms) square wave pulses were deliv-
ered at 3–5 s intervals, and responses were averaged over 40 trials. Field
responses were recorded by using a 1 mm diameter silver ball electrode
placed (i) at T6, three segments caudal to the graft (see Figure 6B). Confirma-
tion of electrical transmission through the graft was confirmed by retransecting
the cord immediately above the graft and by applying kynurenic acid (50mM in
ACSF) to the graft at the T3 segment.
Functional Analysis
The BBB open field 21 point locomotion rating scale (Basso et al., 1996) was
assessed weekly by two independent observers blinded to group identity.
Statistical Analysis
In all quantification procedures and behavioral analyses, observers were
blinded to the nature of the experimental manipulation. Multiple group
comparisons were made using one-way analysis of variance (ANOVA; JMP
software) at a designated significance level of 95%. Two-group comparisons
were tested by Student’s t test. Data are presented as mean ±SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and can be found with this
article online at http://dx.doi.org/10.1016/j.cell.2012.08.020.
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